BRIEF published on 10/24/2025 at 15:55, 1 month 11 days ago Organto Foods Announces Early Debenture Prepayment Financial Position Convertible Debentures Share Conversion Organto Foods Debenture Prepayment
PRESS RELEASE published on 10/24/2025 at 15:50, 1 month 11 days ago Organto Foods Announces Intention to Prepay Outstanding Debentures Organto Foods Inc. announces prepayment of convertible debentures to reduce debt, strengthen financial position. Holders can convert to common shares at $0.60/share Common Shares Financial Position Convertible Debentures Organto Foods Inc. Prepayment
BRIEF published on 09/25/2025 at 19:20, 2 months 9 days ago Organto Foods to Attend Fruit Attraction Conference in Madrid Business Development Organic Produce Organto Foods Fruit Attraction Madrid Conference
PRESS RELEASE published on 09/25/2025 at 19:15, 2 months 9 days ago Organto Foods to Participate in Fruit Attraction Conference in Madrid, Spain Organto Foods Inc. to participate in Fruit Attraction 2025 trade show in Madrid, Spain from Sep 30th to Oct 2nd, enhancing global business opportunities and showcasing organic products Organto Foods Inc. Trade Show Organic Products Fruit Attraction 2025 Global Business Opportunities
BRIEF published on 09/10/2025 at 22:35, 2 months 24 days ago Organto Foods Completes $8 Million Private Placement Private Placement TSX Venture Exchange Financing Organic Products Organto Foods
PRESS RELEASE published on 09/10/2025 at 22:30, 2 months 24 days ago Organto Foods Announces Completion of $8.0 Million Private Placement Financing Organto Foods Inc. completes C$8 million Private Placement, issuing 16,000,000 units at C$0.50 per Unit. Proceeds to support organic product platform and working capital Private Placement Working Capital Stock Exchange Organto Foods Inc. Organic Products
BRIEF published on 08/29/2025 at 23:20, 3 months 6 days ago Organto Foods Secures $8 Million Through Private Placement Private Placement Investment Growth Financial Strategy Organic Products Organto Foods
PRESS RELEASE published on 08/29/2025 at 23:15, 3 months 6 days ago Organto Foods Closes $8.0 Million Private Placement Financing Organto Foods Inc. closes non-brokered private placement of 16,000,000 units for $8.0 million. Proceeds to fuel growth and debt repayment Private Placement Financial News Investment Organto Foods Inc. Organic
BRIEF published on 08/26/2025 at 22:20, 3 months 9 days ago Organto Foods Reports Significant Revenue Growth in Q2 2025 Revenue Growth Financial Improvement Organic Products Organto Foods Q2 2025 Results
PRESS RELEASE published on 08/26/2025 at 22:15, 3 months 9 days ago Organto Foods Announces Second Quarter 2025 Financial Results Organto Foods Inc. reports strong financial results for Q2 2025, with sales up 291% year-over-year. Company shows significant gross profit increase and improved operating costs efficiency Financial Results Sales Increase Organto Foods Inc. Profit Growth Q2 2025
Published on 12/05/2025 at 02:35, 3 hours 52 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 27 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 22 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 27 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 36 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 12 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 17 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 27 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 43 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 26 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
